Evidence map›Paper›PMID 26019536›Full record

ArticleBiotechnology, biotechnological equipment2014

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results.

Asen Hadzhiyanev, Radina Ivanova, Emil Nachev, Atanaska Elenkova, Maria Yaneva, Sabina Zaharieva, Marin Marinov, Jivko Surchev, Asya Ivanova

Open access · goldAbstract read
In one paragraph

Article in Biotechnology, biotechnological equipment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Asen HadzhiyanevDepartment of Neurosurgery, University Hospital 'St. Ivan Rilsky', Medical University of Sofia , Sofia , Bulgaria.
Radina IvanovaClinical Center of Endocrinology and Gerontology, Medical University of Sofia , Sofia , Bulgaria.
Emil NachevClinical Center of Endocrinology and Gerontology, Medical University of Sofia , Sofia , Bulgaria.
Atanaska ElenkovaClinical Center of Endocrinology and Gerontology, Medical University of Sofia , Sofia , Bulgaria.
Maria YanevaClinical Center of Endocrinology and Gerontology, Medical University of Sofia , Sofia , Bulgaria.
Sabina ZaharievaClinical Center of Endocrinology and Gerontology, Medical University of Sofia , Sofia , Bulgaria.
Marin MarinovDepartment of Neurosurgery, University Hospital 'St. Ivan Rilsky', Medical University of Sofia , Sofia , Bulgaria.
Jivko SurchevDepartment of Neurosurgery, University Hospital 'St. Ivan Rilsky', Medical University of Sofia , Sofia , Bulgaria.
Asya IvanovaMedical University of Sofia , Sofia , Bulgaria.
Medical University of Sofia · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pituitary adenomas (PAs) show a broad clinicomorphological spectrum. The proliferation activity, evaluated by MIB-1 labelling index (LI), and p53 expression have been pointed as predictive markers for invasiveness and progression. The aim of this study was to evaluate the proliferation rate and p53 expression and to look for any relationships with the clinical behaviour and follow-up results in a series of Bulgarian patients with PAs. A total of 93 patients with PAs (81 hormone-secreting, 12 non-functioning), who were operated on and followed up for a period of five years, were included. The MIB-1 LI and p53 expressions were determined by immunohistochemistry and correlated with various clinical and tumour variables. The whole group of PAs showed a low proliferation rate with evident variations in a small number of cases (MIB-1 LI - 0.50 ± 0.56, from 0.1 to 3.30). MIB-1 LI correlated with tumour size (

Indexed as

immunohistochemistryp-53 expressionpituitary adenomaproliferation rate

Identifiers

PMID26019536
PMCPMC4433927
OpenAlexW2055668956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.